Federal award
CEPHEID
W911QY20C0124
Contract
Obligated and Ceiling
- Obligated (net)
- $6,754,911.00
- Ceiling (potential value, not spending)
- $8,798,298.00
- Current value
- $6,754,911.00
- Gross positive obligations
- $6,755,966.00
Obligated is what the government has committed, net of de-obligations. The ceiling is the most the award or vehicle could ever reach; it is shown separately and never added to, or compared as, spending.
Award Details
- Recipient
- CEPHEID · W6HQTMWB9Q28
- Owner company
- Not a reviewed companyNo reviewed company owns this recipient.
- Reported parent
- DANAHER CORPORATION · MBFSJ8M4RQB6
- Awarding agency
- Department of War · sub-agency 2100 · office W911QY
- Funding agency
- Department of War · sub-agency 2100
- Product or service (PSC)
- 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS
- Industry (NAICS)
- 325413 · IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURING
- PIID
- W911QY20C0124
- Award type code
- D
- Actions
- 6 · Sep 24, 2020 to Dec 22, 2020
- Why it is listed
- gross positive obligations of $100k or more (contracts)
Action History6
| Date | FY | Mod | Action type | Obligation | Company in company totals |
|---|---|---|---|---|---|
| Dec 22, 2020 | FY2021 | P00005 | M | $680,000.00 | — |
| Nov 16, 2020 | FY2021 | P00004 | M | $0.00 | — |
| Nov 16, 2020 | FY2021 | P00003 | M | $0.00 | — |
| Nov 12, 2020 | FY2021 | P00002 | D | $1,360,000.00 | — |
| Oct 17, 2020 | FY2021 | P00001 | D | −$1,055.00 | — |
| Sep 24, 2020 | FY2020 | 0 | — | $4,715,966.00 | — |
Newest first. Every obligation is shown as reported, including zero and negative (de-obligation) actions. Award lists belong to the company of the latest action; company totals credit each action to the company named on that row, so a note marks rows where the two differ.